September 2022 - Reithera

By ef

Posted September 30, 2022

29th ESGCT Annual Congress

From October 11 to 14, #ReiThera will attend the 𝟮𝟵𝘁𝗵 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗳𝗼𝗿 𝗚𝗲𝗻𝗲 & 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 (#ESGCT) 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 at the Edinburgh International Conference Centre, which brings together [...]

By ef

In News, Publications

Posted September 27, 2022

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomised placebo-controlled phase 2 trial (COVITAR)

· GRAd-COV2 vaccine based on a recently developed group C gorilla adenoviral vector · Phase 2 trial confirms favorable safety profile for single and double dose regimens · [...]